Agios Pharmaceuticals, Inc. (AGIO) |
| 33.3 0.15 (0.45%) 04-14 16:00 |
| Open: | 32.99 |
| High: | 33.9 |
| Low: | 32.915 |
| Volume: | 642,325 |
| Market Cap: | 1,951(M) |
| PE Ratio: | -4.68 |
| Exchange: | NASDAQ Global Select |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 42.46 |
| Resistance 1: | 36.35 |
| Pivot price: | 32.41 |
| Support 1: | 30.57 |
| Support 2: | 27.00 |
| 52w High: | 46 |
| 52w Low: | 22.24 |
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
Financials
| EPS | -7.120 |
| Book Value | 20.410 |
| PEG Ratio | 0.00 |
| Gross Profit | -4.981 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | -608.90 |
| Return on Assets (ttm) | -19.9 |
| Return on Equity (ttm) | -30.2 |
Company news
Thu, 09 Apr 2026
What Agios Pharmaceuticals (AGIO)'s FDA-Backed Accelerated Path for Mitapivat in Sickle Cell Disease Means For Shareholders - Sahm
Mon, 06 Apr 2026
Agios (NASDAQ: AGIO) CLO exercises 8,500 PSUs and sells shares for taxes - Stock Titan
Mon, 06 Apr 2026
[Form 4] AGIOS PHARMACEUTICALS, INC. Insider Trading Activity - Stock Titan
Mon, 06 Apr 2026
Agios (NASDAQ: AGIO) CFO exercises PSUs, automatic share sale for taxes - Stock Titan
Fri, 03 Apr 2026
AGIO SEC Filings - Agios Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Wed, 01 Apr 2026
Lost Money on Agios Pharmaceuticals, Inc.(AGIO)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky - PR Newswire
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
